𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HER-2, TOP2A and chromosome 17 alterations in breast cancer

✍ Scribed by Asli Rehber Beser; Sitki Tuzlali; Deniz Guzey; Semra Dolek Guler; Seniha Hacihanefioglu; Nejat Dalay


Publisher
Springer Netherlands
Year
2007
Tongue
English
Weight
200 KB
Volume
13
Category
Article
ISSN
1219-4956

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


HER-2 and TOP2A coamplification in urina
✍ Ronald Simon; Ramin Atefy; Urs Wagner; Thomas Forster; AndrΓ© Fijan; James Bruder πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 357 KB

## Abstract __HER‐2/NEU__ is one of the most frequently amplified oncogenes and a potential therapeutic target in bladder cancer. In breast cancer, the adjacent __TOP2A__ gene, the molecular target for several anticancer drugs, is frequently coamplified together with __HER‐2__. To study the amplifi

Lower HER-2/chromosome enumeration probe
✍ Itoh, Hitoshi ;Miyajima, Yoko ;Umemura, Shinobu ;Osamura, Robert Y. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 251 KB

## Background: Fluorescence in situ hybridization (fish) is the gold standard for assessing her-2 status for breast cancers, and paraffin-embedded tissue sections are used routinely for her-2 fish. cytologic samples also are used, but to the authors' knowledge, little is known regarding the reliabi

Targeting chromosomal instability and tu
✍ Rebecca A. Burrell; Nicolai Juul; Stephen R. Johnston; Jorge S. Reis-Filho; Zolt πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 181 KB

## Abstract Chromosomal instability (CIN) is a common cause of tumour heterogeneity and poor prognosis in solid tumours and describes cell–cell variation in chromosome structure or number across a tumour population. In this article we consider evidence suggesting that CIN may be targeted and may in

Chromosome band 17q21 in breast cancer:
✍ Tiziana Negri; Eva Tarantino; Marta Orsenigo; James F. Reid; Manuela Gariboldi; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 241 KB

## Abstract Treatment success of breast cancer patients with trastuzumab alone or in combination depends not only on __HER2/NEU__ amplification but also on __PTEN__ and PI3K status and efficient cell death programs. In this pilot study, we found a significant association between loss of __beclin 1_

Assessment of HER2 gene status in breast
✍ Semir Vranic; Bryan Teruya; Susan Repertinger; Pamela Ulmer; Jill Hagenkord; Zor πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 216 KB

## Abstract ## BACKGROUND: The current study was performed to determine the impact of polysomy 17 on the interpretation of __HER2__ testing of invasive breast carcinomas using fluorescent in situ hybridization methods. Current American Society of Clinical Oncology/College of American Pathologists